ARCA biopharma
Genetically-targeted therapies for cardiovascular diseases.
Launch date
Employees
Market cap
€50.2m
Enterprise valuation
€20m (Public information from Aug 2024)
Share price
$28.8 ABIO
Westminster Colorado (HQ)
Authorizing premium user...